BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.970
-0.040 (-1.99%)
At close: Oct 8, 2025, 4:00 PM EDT
1.970
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:00 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $14.84 million as of October 8, 2025. Its market cap has decreased by -11.64% in one year.
Market Cap
14.84M
Enterprise Value
-2.05M
1-Year Change
-11.64%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $14.84M, a decrease of -71.45%. That is a compound annual growth rate of -21.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 15.10M | -57.46% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |